Cited by 484Antifungal resistance and susceptibilityBacterial Identification and Susceptibility TestingYeasts and Rust Fungi Studies

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Open access

Pfaller, M. A., Diekema, D. J.·2012·Journal of Clinical Microbiology

DOI 10.1128/jcm.00937-12PMC PMC3421803

Open this paper in CoChat — free account Open PDF

Abstract

Antifungal susceptibility testing of Candida has been standardized and refined and now may play a useful role in managing Candida infections. Important new developments include validation of 24-h reading times for all antifungal agents and the establishment of species-specific epidemiological cutoff values (ECVs) for the systemically active antifungal agents and both common and uncommon species of Candida . The clinical breakpoints (CBPs) for fluconazole, voriconazole, and the echinocandins have been revised to provide species-specific interpretive criteria for the six most common species. The revised CBPs not only are predictive of clinical outcome but also provide a more sensitive means of identifying those strains with acquired or mutational resistance mechanisms. This brief review serves as an update on the new developments in the antifungal susceptibility testing of Candida spp. using Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) methods.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/jcm.00937-12

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,811
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Candida and candidiasis.
Calderone, R. (2012) · ASM Press eBooks · Cited by 912
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Self-citation
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Self-citation

Show all 105 references

Research works printed but not linked: 1

PfallerMA DiekemaDJ. 2007. Azole antifungal drug cross-resistance: mechanisms, epidemiology, and clinical significance. J. Invasive Fungal Infect. 1:74–92.

Sorted by citations

Items 201–300 of 481

Multicenter Evaluation of the New Vitek 2 Yeast Susceptibility Test Using New CLSI Clinical Breakpoints for Fluconazole
Pfaller, M. A., Diekema, D. J., Procop, G. W., & Wiederhold, N. P. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00658-14 · Cited by 22
Self-citation
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010
Yang, Y.-L., Chen, H., Lin, C.-C., Chu, W.-L., & Lo, H. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.03.003 · Cited by 22
Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati
Hirayama, T., Miyazaki, T., Yamagishi, Y., Mikamo, H., Ueda, T., Nakajima, K., Takesue, Y., Higashi, Y., Yamamoto, Y., Kimura, M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02528-17 · Cited by 22
Discovery of Benzylthio Analogs of Fluconazole as Potent Antifungal Agents
Motahari, K., Badali, H., Hashemi, S. M., Fakhim, H., Mirzaei, H., Vaezi, A., Shokrzadeh, M., & Emami, S. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0295 · Cited by 22
Incidence and spectrum of yeast species isolated from the oral cavity of Iranian patients suffering from hematological malignancies
Arastehfar, A. A., Daneshnia, F., Farahyar, S., Fang, W., Salimi, M., Salehi, M., Hagen, F., Weihua, P., Roudbary, M., & Boekhout, T. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2019.1601061 · Cited by 23
Chitosan-Based Films with 2-Aminothiophene Derivative: Formulation, Characterization and Potential Antifungal Activity
Oliveira, V. D. S., da Cruz, M. M., Bezerra, G. S., Silva, N. E. S. E., Nogueira, F. H. A., Chaves, G. M., Soares‐Sobrinho, J. L., Mendonça, F. J. B., Damasceno, B. P. G. D. L., Converti, A., et al. (2022) · Marine Drugs · doi:10.3390/md20020103 · Cited by 22
Candidaemia in the non-neutropenic patient: A critique of the guidelines
Deshpande, A., Gaur, S., & Bal, A. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.005 · Cited by 24
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Rhimi, W., Aneke, C. I., Annoscia, G., Camarda, A., Mosca, A., Cantacessi, C., Otranto, D., & Cafarchia, C. (2020) · International Microbiology · doi:10.1007/s10123-020-00141-1 · Cited by 21
In Vitro Biofilm Formation by Malassezia pachydermatis Isolates and Its Susceptibility to Azole Antifungals
Čonková, E., Proškovcová, M., Váczi, P., & Malinovská, Z. (2022) · Journal of Fungi · doi:10.3390/jof8111209 · Cited by 21
Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan
Chang, T.-P., Lo, P.-C., Wang, A.-H., Lo, H., Ho, M., Yang, Y.-L., & Lin, P. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-013-0623-8 · Cited by 21
Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis
González-Lara, M. F., Torres‐González, P., Cornejo‐Juárez, P., Velázquez-Acosta, C., Martínez‐Gamboa, A., Rangel‐Cordero, A., Bobadilla-del-Valle, M., Ostrosky-Zeichner, L. L., Ponce‐de‐León, A., & Sifuentes‐Osornio, J. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2846-2 · Cited by 23
Evaluation of the Potential Probiotic Yeast Characteristics with Anti-MRSA Abilities
Shen, Y., Bai, X., Zhang, Y., Gao, Q., Bu, X., Xu, Y., & Guo, N. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09942-4 · Cited by 21
Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases
Arastehfar, A. A., Fang, W., Al‐Hatmi, A. M. S., Afsarian, M. H., Daneshnia, F., Bakhtiari, M., Sadati, S. K., Badali, H., Khodavaisy, S., Hagen, F., et al. (2018) · Medical Mycology · doi:10.1093/mmy/myy148 · Cited by 21
A comparative investigation of azole susceptibility inCandidaisolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana
Adjapong, G., Hale, M. L., & Garrill, A. (2016) · Medical Mycology · doi:10.1093/mmy/myw122 · Cited by 21
Rapid emergence of FKS mutations in Candida glabrata isolates in a peritoneal candidiasis
Sasso, M., Roger, C., & Lachaud, L. (2017) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2017.04.004 · Cited by 20
In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs
Zomorodian, K., Bandegani, A., Mirhendi, H., Pakshir, K., Alinejhad, N., & Poostforoush Fard, A. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.28666 · Cited by 20
Reversal of azole resistance in Candida albicans by oridonin
Chen, H., Li, H., Duan, C., Song, C., Peng, Z., Li, H., & Shi, W. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.10.025 · Cited by 20
Characterization and Physical and Biological Properties of Tissue Conditioner Incorporated with Carum copticum L.
Hejazi, M., Zareshahrabadi, Z., Ashayeri, S., Saharkhiz, M. J., Iraji, A., Alishahi, M., & Zomorodian, K. (2021) · BioMed Research International · doi:10.1155/2021/5577760 · Cited by 20
Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China
Yan, L., Wang, X.-D., Seyedmousavi, S., Yuan, J.-N., Abulize, P., Pan, W., Yu, N., Yang, Y., Hu, H.-Q., Liao, W., et al. (2019) · Mycopathologia · doi:10.1007/s11046-018-0305-2 · Cited by 20
Echinocandin persistence directly impacts the evolution of resistance and survival of the pathogenic fungus Candida glabrata
Arastehfar, A., Daneshnia, F., Floyd, D. J., Jeffries, N. E., Salehi, M., Perlin, D. S., Ilkit, M., Lass-Flöerl, C., & Mansour, M. K. (2024) · mBio · doi:10.1128/mbio.00072-24 · Cited by 19
Nationwide Surveillance of Antifungal Resistance of Candida Bloodstream Isolates in South Korean Hospitals: Two Year Report from Kor-GLASS
Won, E. J., Choi, M. J., Jeong, S. H., Kim, D., Shin, K. S., Shin, J. H., Kim, Y. R., Kim, H. S., Kim, Y. A., Uh, Y., et al. (2022) · Journal of Fungi · doi:10.3390/jof8100996 · Cited by 19
COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance
Najafzadeh, M. J., Shaban, T., Zarrinfar, H., Sedaghat, A., Hosseinikargar, N., Berenji, F., Jalali, M., Lackner, M., James, J. E., İlkit, M., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae031 · Cited by 19
Molecular epidemiology of invasive Candida albicans at a tertiary hospital in northern Taiwan from 2003 to 2011
WANG, S., Shen, M., Lin, H., Sun, P., Lo, H., & Lu, J. (2015) · Medical Mycology · doi:10.1093/mmy/myv065 · Cited by 19
Molecular Characterization ofCandida africanain Genital Specimens in Shanghai, China
Hu, Y., Yu, A., Chen, X., Wang, G., & Feng, X. (2015) · BioMed Research International · doi:10.1155/2015/185387 · Cited by 19
In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis
De-la-Torre, J., Ortiz-Samperio, M. E., Marcos‐Arias, C., Marichalar‐Mendía, X., Eraso, E., Goicouria, M. Á. E., Urízar, J. M. A., & Quindós, G. (2017) · Mycopathologia · doi:10.1007/s11046-017-0112-1 · Cited by 19
In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates
Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Majoros, L., & Kovács, R. (2017) · Medical Mycology · doi:10.1093/mmy/myx062 · Cited by 19
Risk Factors and Outcomes of Recurrent Candidemia in Children: Relapse or Re-Infection?
Lai, M., Hsu, J., Chu, S., Wu, I.-H., Huang, H., Chiang, M., Fu, R.-H., & Tsai, M.-H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010099 · Cited by 19
Species distribution and antifungal susceptibility patterns of Candida species: Is low susceptibility to itraconazole a trend in Malaysia?
Santhanam, J., Nazmiah, N., & Aziz, M. N. (2013) · PubMed · Cited by 19
Anti-Candida Potential of Sclareol in Inhibiting Growth, Biofilm Formation, and Yeast–Hyphal Transition
Kim, C., Kim, J.-G., & Kim, K.-Y. (2023) · Journal of Fungi · doi:10.3390/jof9010098 · Cited by 18
Exploring the Potential Mechanism of Action of Piperine against Candida albicans and Targeting Its Virulence Factors
Bravo-Chaucanés, C. P., Chitiva, L. C., Vargas‐Casanova, Y., Diaz-Santoyo, V., Hernández-Martínez, A. X., Costa, G. M., & Parra‐Giraldo, C. M. (2023) · Biomolecules · doi:10.3390/biom13121729 · Cited by 20
Enrichment of creatine-gelatin cryogel with Zataria multiflora essential oil and titanium dioxide nanoparticles as a potential wound dressing
Hashempur, M. H., Karami, F., Khoshnam, M., Zomorodian, K., Zare, A., Jafari, M., Pesaran, S., & Zareshahrabadi, Z. (2024) · Materials Today Chemistry · doi:10.1016/j.mtchem.2024.102069 · Cited by 18
Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years
Francesco, M. A. D., Piccinelli, G., Gelmi, M. L., Gargiulo, F., Ravizzola, G., Pinsi, G., Peroni, L., Bonfanti, C., & Caruso, A. (2017) · Mycopathologia · doi:10.1007/s11046-017-0155-3 · Cited by 18
Epidemiology and antifungal susceptibility testing of non-albicans Candida species colonizing mucosae of HIV-infected patients in Yaoundé (Cameroon)
Ngouana, T. K., Toghueo, R. M. K., Tsague, I. F. K., Lachaud, L., Nana, A. K., Tadjou, L., Kouanfack, C., Boyom, F. F., & Bertout, S. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.06.003 · Cited by 18
Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species
Lim, H. J., Shin, J. H., Kim, M., Yong, D., Byun, S. A., Choi, M. J., Lee, S. Y., Won, E. J., Kee, S., Kim, S. H., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00740-20 · Cited by 18
Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III study
Sedik, S., Egger, M., Wolfgruber, S., Salmanton‐García, J., Bassetti, M., Mikulska, M., Özenci, V., Arıkan-Akdağlı, S., Akova, M., Gangneux, J., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106629 · Cited by 17
Resistant C. albicans implicated in recurrent vulvovaginal candidiasis (RVVC) among women in a tertiary healthcare facility in Kumasi, Ghana
Sarpong, A. K., Odoi, H., Boakye, Y. D., Boamah, V. E., & Agyare, C. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03217-6 · Cited by 18
Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin
Marcos-Zambrano, L. J., Escribano, P., Rueda, C., Zaragoza, Ó., Bouza, E., & Guinea, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01032-13 · Cited by 17
Temporal Expression of Genes in Biofilm-Forming Ocular Candida albicans Isolated From Patients With Keratitis and Orbital Cellulitis
Ranjith, K., Chakravarthy, S. K., Adicherla, H., Sharma, S., & Shivaji, S. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22933 · Cited by 17
Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins
Chassot, F., Venturini, T. P., Piasentin, F. B., Rossato, L. L., Fiorini, A., Svidzinski, T. I. E., & Alves, S. H. (2016) · Mycopathologia · doi:10.1007/s11046-016-0028-1 · Cited by 18
High prevalence of Itraconazole Resistance among Candida parapsilosis isolated from Iran
Hassanmoghadam, F., Shokohi, T., Hedayati, M. T., Aslani, N., Haghani, I., Nabili, M., Lotfali, E., & Moazeni, M. (2019) · Current Medical Mycology · doi:10.18502/cmm.5.3.1746 · Cited by 16
Isolation of cholesterol-dependent, multidrug-resistant Candida glabratastrains from blood cultures of a candidemia patient in Kuwait
Khan, Z., Ahmad, S., Joseph, L., & Alobaid, K. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-188 · Cited by 16
Epidemiological characterization of Acinetobacter baumannii bloodstream isolates from a Chinese Burn Institute: A three-year study
Huang, G., Yin, S., Xiang, L., Gong, Y., Sun, K., Luo, X., Zhang, C., Yang, Z., Deng, L., Jiang, B., et al. (2016) · Burns · doi:10.1016/j.burns.2016.02.021 · Cited by 16
Intestinal Candida parapsilosis isolates from Rett syndrome subjects bear potential virulent traits and capacity to persist within the host
Strati, F., Calabrò, A., Donati, C., Felice, C. D., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., Rizzetto, L., Filippo, C. D., et al. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0785-z · Cited by 16
Antifungal Resistance Testing and Implications for Management
Badali, H., & Wiederhold, N. P. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00354-6 · Cited by 16
Comparative genomic analysis of clinical Candida glabrata isolates identifies multiple polymorphic loci that can improve existing multilocus sequence typing strategy
Arastehfar, A. A., Marcet‐Houben, M., Daneshnia, F., Taj‐Aldeen, S. J., Batra, D. G., Lockhart, S. R., Shor, E., Gabaldón, T., & Perlin, D. S. (2021) · Studies in Mycology · doi:10.1016/j.simyco.2021.100133 · Cited by 15
Incidence, susceptibility and outcomes of candidemia in adults living in Calgary, Alberta, Canada (2010–2018)
Bourassa‐Blanchette, S., Biesheuvel, M. M., Lam, J. C., Kipp, A. J., Church, D. L., Carson, J. A., Dalton, B., Parkins, M. D., Barkema, H. W., & Gregson, D. B. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08050-0 · Cited by 17
Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units—An In Vitro Study
Nouri, N., Mohammadi, S. R., Beardsley, J., Aslani, P., Ghaffarifar, F., Roudbary, M., & Rodrigues, C. F. (2023) · Metabolites · doi:10.3390/metabo13040580 · Cited by 15
The best type of inoculum for testing the antifungal drug susceptibility of Microsporum canis: In vivo and in vitro results
Aneke, C. I., Rhimi, W., Pellicoro, C., Cantacessi, C., Otranto, D., & Cafarchia, C. (2020) · Mycoses · doi:10.1111/myc.13090 · Cited by 15
Susceptibility pattern of Candida albicans isolated from Iranian patients to antifungal agents
Badiee, P., Badali, H., Diba, K., Moghadam, A. G., Hosseininasab, A., Jafarian, H., Mohammadi, R., Mirhendi, H., Najafzadeh, M. J., Shamsizadeh, A., et al. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.1.24 · Cited by 15
The changes of antifungal susceptibilities caused by the phenotypic switching of Candida species in 229 patients with vulvovaginal candidiasis
Tang, Y., Fan, Y., Huang, L., & Hu, Z. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22644 · Cited by 15
Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic review
Gülmez, D., Alp, Ş., Gürsoy, G., Ayaz, Ç. M., Doğan, Ö., Arıkan-Akdağlı, S., & Akova, M. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.030 · Cited by 15
Clinical and Microbiological Investigation of Fungemia from Four Hospitals in China
Dong, D., Li, Z., Zhang, L., Jiang, C., Mao, E., Wang, X., & Peng, Y. (2015) · Mycopathologia · doi:10.1007/s11046-014-9855-0 · Cited by 15
Candida and Candidiasis
Aşkun, T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100869 · Cited by 15
Species Distribution and Antifungal Susceptibility Pattern of Candida Recovered from Intensive Care Unit Patients, Vietnam National Hospital of Burn (2017–2019)
Sinh, C. T., Loi, C. B., Minh, N. T., Lam, N. N., Quang, D. X., Đỗ, Q., Ánh, Đ. N., Hien, T. T. T., Su, H. X., & Le, T. (2021) · Mycopathologia · doi:10.1007/s11046-021-00569-7 · Cited by 16
The Emergence of Echinocandin-Resistant Candida glabrata Exhibiting High MICs and Related FKS Mutations in Turkey
Sığ, A. K., Sönmezer, M. Ç., Gülmez, D., Duyan, S., Uzun, Ö., & Arıkan-Akdağlı, S. (2021) · Journal of Fungi · doi:10.3390/jof7090691 · Cited by 14
Multi-probe Real-Time PCR Identification of Four Common Candida Species in Blood Culture Broth
Foongladda, S., Mongkol, N., Petlum, P., & Chayakulkeeree, M. (2014) · Mycopathologia · doi:10.1007/s11046-014-9743-7 · Cited by 14
Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007–2012: impact of new antifungal breakpoints
Chen, Y., Kuo, S., Chen, F., & Lee, C. (2016) · Mycoses · doi:10.1111/myc.12553 · Cited by 15
Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin
Teixeira‐Santos, R., Ricardo, E., Branco, R. J. F., Azevedo, M. M., Rodrigues, A. G., & Pina‐Vaz, C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01439 · Cited by 14
First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern
Treviño‐Rangel, R. D. J., Espinosa-Pérez, J. F., Villanueva‐Lozano, H., Montoya, A. M., Andrade, Á., Bonifáz, A., & González, G. M. (2018) · Folia Microbiologica · doi:10.1007/s12223-018-0592-5 · Cited by 14
Impact of high MIC of fluconazole on outcomes of Candida glabrata bloodstream infection: a retrospective multicenter cohort study
Ko, J., Peck, K. R., Jung, D. S., Lee, J. Y., Kim, H. A., Ryu, S. Y., Jung, S., Joo, E., Cheon, S., Ys, K., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.05.001 · Cited by 14
Corrigendum: Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases
Arastehfar, A. A., Fang, W., Al‐Hatmi, A. M. S., Afsarian, M. H., Daneshnia, F., Bakhtiari, M., Sadati, S. K., Badali, H., Khodavaisy, S., Hagen, F., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myz025 · Cited by 14
Evaluation of the BD Phoenix system for identification of a wide spectrum of clinically important yeast species: a comparison with Vitek 2-YST
Won, E. J., Shin, J. H., Kim, M., Choi, M. J., Joo, M. Y., Kee, S., Shin, M., Suh, S., & Ryang, D. W. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.05.011 · Cited by 13
High Therapeutic Index α-Helical AMPs and Their Therapeutic Potential on Bacterial Lung and Skin Wound Infections
Ouyang, X., Li, B., Yang, T., Yang, Y., Ba, Z., Zhang, J., Yang, P., Liu, Y., Wang, Y., Zhao, Y., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00706 · Cited by 13
In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
Jang, M. J., Shin, J. H., Lee, W. G., Kim, M., Lee, K., Lee, H. S., Lee, M., Chang, C. L., Jang, H., Song, E. S., et al. (2013) · Annals of Laboratory Medicine · doi:10.3343/alm.2013.33.3.167 · Cited by 13
Antifungal susceptibility testing results of New Zealand yeast isolates, 2001–2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species
Morris, A. J., Rogers, K. C., McKinney, W. P., Roberts, S., & Freeman, J. T. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.02.014 · Cited by 13
Epidemiology And Antifungal Susceptibility Patterns Of Invasive Fungal Infections From 2012 To 2014 In A Teaching Hospital In Central China
Xu, H., Yu, S.-Y., Zhou, M., Ning, Y., Xiao, M., Li, X.-G., Chen, M., Kong, F., Chen, S. C.-J., Ming, L., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s227839 · Cited by 13
Species identification and antifungal susceptibility of uncommon blood yeast isolates
Li, M.-C., Tang, H.-J., Wu, C.-J., Wang, S.-W., Su, S.-L., Liu, W., Ko, W., & Chen, Y. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.01.009 · Cited by 13
Phospholipid-Conjugated PEG-b-PCL Copolymers as Precursors of Micellar Vehicles for Amphotericin B
Arias, E. R., Angarita-Villamizar, A. V., Baena, Y., Parra‐Giraldo, C. M., & Pérez, L. D. (2021) · Polymers · doi:10.3390/polym13111747 · Cited by 13
Biocompatible solvent selection based on thermodynamic and computational solubility models, in-silico GastroPlus prediction, and cellular studies of ketoconazole for subcutaneous delivery
Hussain, A., Alshehri, S., Ramzan, M., Afzal, O., Altamimi, A. S. A., & Alossaimi, M. A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102699 · Cited by 13
Evaluation of synergistic anticandidal activity of Galenia africana extract and fluconazole against Candida albicans and Candida glabrata
Nguni, T. L., Abrantes, P. M. D. S., McArthur, C. P., Klaasen, J. A., & Fielding, B. C. (2021) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2021.100503 · Cited by 13
Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system
Cheng, J.-W., Liao, K., Kudinha, T., Yu, S.-Y., Xiao, M., Wang, H., Kong, F., & Xu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01106-7 · Cited by 13
Antifungal susceptibility pattern and biofilm-related genes expression in planktonic and biofilm cells of Candida parapsilosis species complex
Modiri, M., Hashemi, S. J., Ghazvini, R. D., Khodavaisy, S., Ahmadi, A., Ghaffari, M., & Rezaie, S. (2019) · Current Medical Mycology · doi:10.18502/cmm.5.4.1950 · Cited by 14
The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods
Ben-Ami, R., Hilerowicz, Y., Novikov, A., & Giladi, M. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.02.008 · Cited by 12
Analytical techniques for assessing antimicrobial resistance: Conventional solutions, contemporary problems and futuristic outlooks
Kannan, E. P., Gopal, J., & Muthu, M. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117843 · Cited by 12
Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China
Yu, S.-Y., Zhang, L., Chen, S., Kong, F., Xiao, M., Wang, H., Hou, X., Zhou, M., Zhang, G., Zhang, J., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s199359 · Cited by 12
Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study
Wang, Y., Yang, Q., Chen, L., Liu, L., Hao, R., Zhang, T., Wang, X., Lei, J., Xie, J., & Dong, Y. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3034-4 · Cited by 12
Strategies for Antimicrobial Stewardship in Solid Organ Transplant Recipients
Hand, J. M. (2018) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.04.003 · Cited by 12
Virulence and antifungal susceptibility of microsatellite genotypes of Candida albicans from superficial and deep locations
Wang, M., Cao, Y., Xia, M., Al‐Hatmi, A. M. S., Ou, W., Wang, Y., Sibirny, A. А., Zhao, L., Zou, C., Liao, W., et al. (2019) · Yeast · doi:10.1002/yea.3397 · Cited by 12
Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex
Khodavaisy, S., Badali, H., Meis, J. F. G. M., Modiri, M., Mahmoudi, S., Abtahi, H., Salehi, M., Manshadi, S. A. D., Aala, F., Afshari, S. A. K., et al. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.100968 · Cited by 12
Isolation and Identification of Effective Probiotics on Drug-Resistant Acinetobacter baumannii Strains and Their Biofilms
Abbasi, Z., Ghasemi, S. M., Ahmadi, Y., & Shokri, D. (2024) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2024/8570521 · Cited by 11
Wild and partially synanthropic bird yeast diversity, in vitro virulence, and antifungal susceptibility of Candida parapsilosis and Candida tropicalis strains isolated from feces
Glushakova, A., & Kachalkin, A. (2023) · International Microbiology · doi:10.1007/s10123-023-00437-y · Cited by 12
Anidulafungin versus Caspofungin in a Mouse Model of Candidiasis Caused by Anidulafungin-Susceptible Candida parapsilosis Isolates with Different Degrees of Caspofungin Susceptibility
Dimopoulou, D., Hamilos, G., Tzardi, M. N., Lewis, R. E., Samonis, G., & Kontoyiannis, D. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01025-13 · Cited by 11
Species distribution and antifungal susceptibility to vulvovaginalCandidaspp. in southern Mato Grosso State, Brazil
Goulart, L. S., Santiago, E. F., Ramon, J. L., de Moura, S. V., Silva, A. R., Silva, I. F., Chávez‐Pavoni, J. H., & de Araújo, C. (2016) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.5935/1676-2444.20160039 · Cited by 11
Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients
Sharifynia, S., Rezaie, S., Mohamadnia, A., Mortezaee, V., Hadian, A., & Seyedmousavi, S. (2018) · Medical Mycology · doi:10.1093/mmy/myy016 · Cited by 11
Cutaneous candidiasis in Tehran-Iran: from epidemiology to multilocus sequence types, virulence factors and antifungal susceptibility of etiologic Candida species
Sadeghi, G., Ebrahimi‐Rad, M., Shams‐Ghahfarokhi, M., Jahanshiri, Z., Mirabzadeh, E., Eslamifar, A., Mousavi, S. F., & Razzaghi‐Abyaneh, M. (2019) · Iranian Journal of Microbiology · doi:10.18502/ijm.v11i4.1463 · Cited by 11
Increasing Trends of Reduced Susceptibility to Antifungal Drugs Among Clinical Candida glabrata Isolates in Kuwait
Khan, Z., Ahmad, S., Al‐Sweih, N., Mokaddas, E. M., Al-Banwan, K., Alfouzan, W. A., Al‐Obaid, I., Alobaid, K., & Varghese, S. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0437 · Cited by 11
Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia
Falces‐Romero, I., Romero‐Gómez, M. P., Moreno-Ramos, F., Mingorance, J., García‐Rodríguez, J., & Cendejas‐Bueno, E. (2020) · Medical Mycology · doi:10.1093/mmy/myaa056 · Cited by 11
Clinical Characteristics and Outcomes of Candidemia Caused by Meyerozyma guilliermondii Complex in Cancer Patients Undergoing Surgery
Chen, J., Tian, S., Li, F., Sun, G., Yun, K., Cheng, S., & Chu, Y. (2020) · Mycopathologia · doi:10.1007/s11046-020-00485-2 · Cited by 11
Determinants of fluconazole resistance and the efficacy of fluconazole and milbemycin oxim combination against Candida parapsilosis clinical isolates from Brazil and Turkey
Daneshnia, F., Polat, S. H., İlkit, M., Shor, E., de Almeida, J. N., Favarello, L. M., Colombo, A. L., Arastehfar, A. A., & Perlin, D. S. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.906681 · Cited by 11
Azole Resistance in Candida albicans Isolates from Oropharyngeal Candidiasis is Associated with ERG11 Mutation and Efflux Overexpression
Jahanshiri, Z., Manifar, S., Arastehnazar, F., Hatami, F., & Lotfali, E. (2022) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-131046 · Cited by 11
Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020
Nishida, R., Eriguchi, Y., Miyake, N., Nagasaki, Y., Yonekawa, A., Mori, Y., Kato, K., Akashi, K., & Shimono, N. (2023) · Medical Mycology · doi:10.1093/mmy/myad056 · Cited by 10
Global prevalence and trends of fluconazole resistance in non-albicans Candida species: a systematic review and meta-analysis
Li, X., Sholeh, M., Moghadam, M. A., Ostadrahimi, M., & Hosseini, S. S. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12653-8 · Cited by 12
New Insights Regarding Yeast Survival following Exposure to Liposomal Amphotericin B
Teixeira‐Santos, R., Ricardo, E., Guerreiro, S. G., Costa‐de‐Oliveira, S., Rodrigues, A. G., & Pina‐Vaz, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00575-15 · Cited by 10
Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms
Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., & Kovács, R. (2018) · Medical Mycology · doi:10.1093/mmy/myy108 · Cited by 10
Antifungal susceptibility, species distribution and risk factors associated with mortality of invasive candidiasis in children in Turkey: A six-year retrospective, single-centre study
Yakut, N., Kepenekli, E., Ergenç, Z., Baran, E., & Çerikçioğlu, N. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101082 · Cited by 10
Genetic Mutations in FKS1 Gene Associated with Acquired Echinocandin Resistance in Candida parapsilosis Complex
Khalifa, H. O., Watanabe, A., & Kamei, K. (2024) · Mycopathologia · doi:10.1007/s11046-024-00847-0 · Cited by 10
The Role of New Posaconazole Formulations in the Treatment of Candida albicans Infections: Data from an In Vitro Pharmacokinetic-Pharmacodynamic Model
Beredaki, M.-I., Arendrup, M. C., Andes, D. R., Mouton, J. W., & Meletiadis, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-20 · Cited by 10
In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infections
Beredaki, M.-I., Arendrup, M. C., Mouton, J. W., & Meletiadis, J. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106291 · Cited by 10
Molecular epidemiology, antifungal susceptibility and virulence factors of Candida glabrata complex strains in Kayseri/Turkey
Kaan, Ö., Koç, A. N., Atalay, M. A., & Sarıgüzel, F. M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104870 · Cited by 10
Invasive Fungal Infections and Approaches to Their Diagnosis
Pfaller, M. A. (2015) · Methods in microbiology · doi:10.1016/bs.mim.2015.05.002 · Cited by 11
Self-citation

Authors: Pfaller, M. A., & Diekema, D. J.
Affiliations: University of Iowa (US)
ORCID: Pfaller, M. A.
Diekema, D. J.
Venue: Journal of Clinical Microbiology
Publisher: American Society for Microbiology
Published: 2012-09
Volume: 50
Issue: 9
Pages: 2846-2856
ISSN: 0095-1137 (ISSN-L)
1098-660X
DOI: 10.1128/jcm.00937-12
PMC: PMC3421803
OpenAlex: W2120299440
Cited by: 484
References: 105
Citations by year: 2026: 15 · 2025: 20 · 2024: 24 · 2023: 29 · 2022: 26 · 2021: 41 · 2020: 41 · 2019: 31 · 2018: 43 · 2017: 46 · 2016: 45 · 2015: 41 · 2014: 47 · 2013: 31 · 2012: 4
FWCI: 4.88
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Clinical Microbiology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Pfizer
Eisai
Astellas Pharma
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords: Candida, antifungal susceptibility testing, broth microdilution, epidemiological cut-off values, clinical breakpoints, fluconazole, voriconazole, echinocandins, antifungal resistance, Candida species, CLSI guidelines
MeSH terms: Antifungal Agents, Candida, Candidiasis, Humans, Microbial Sensitivity Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks